Validation of the Brief Negative Symptom Scale and its association with functioning

Area of Science:

• Psychiatry
• Clinical Psychology

Background:

• Negative symptoms are core features of schizophrenia, impacting patient prognosis.
• The Brief Negative Symptom Scale (BNSS) assesses five NIMH-proposed negative symptom domains.
• These domains can be clustered into Motivation-Pleasure (MAP) and Emotional Expressivity (EE) factors.

Purpose of the Study:

• To evaluate the psychometric properties of the BNSS in individuals with schizophrenia.
• To investigate the association between BNSS-measured negative symptoms and overall functioning.

Main Methods:

• 274 schizophrenia patients were assessed using BNSS, PANSS, SANS, GAF, CDSS, and SAS.
• Psychometric properties including internal consistency (Cronbach's alpha) and validity were examined.
• Confirmatory factor analyses explored the BNSS factor structure, and regression models assessed the association with functioning (GAF).

Main Results:

• BNSS demonstrated good internal consistency (Cronbach's alpha = 0.880) and validity.
• A five-factor model provided a better fit than a two-factor model; a second-order model was superior to both.
• Higher scores on BNSS Total, MAP, Avolition, and Asociality were significantly associated with lower Global Assessment of Functioning (GAF) scores.

Conclusions:

• The BNSS is a reliable and valid tool for assessing negative symptoms in schizophrenia.
• Composite scores can be derived from the five-factor or second-order models.
• Negative symptoms, particularly those related to motivation-pleasure (MAP), avolition, and asociality, are strongly linked to impaired functioning.